Literature DB >> 27834005

FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?

Andrea Papadia1, Maria Luisa Gasparri2,3, Franziska Siegenthaler2, Sara Imboden2, Stefan Mohr2, Michael D Mueller2.   

Abstract

PURPOSE: To compare two surgical strategies used to identify lymph node metastases in patients with preoperative diagnosis of complex atypical hyperplasia (CAH), grade 1 and 2 endometrial cancer (EC).
METHODS: Data on patients with preoperative diagnosis of CAH, grade 1 and 2 EC undergoing laparoscopic indocyanine green (ICG) sentinel lymph node (SLN) mapping followed by frozen section of the uterus were collected. When risk factors were identified at frozen section, patients were subjected to a systematic lymphadenectomy. False negative (FN) rates, negative predictive values (NPV), positive predictive values (PPV) and correlation with stage IIIC EC were calculated for the systematic lymphadenectomy based on frozen section of the uterus and for the SLN mapping.
RESULTS: Six (9.5%) out of 63 patients had lymph nodal metastases. Based on frozen section of the uterus, 22 (34.9%) and 15 (22.2%) patients underwent a pelvic and a pelvic and paraaortic lymphadenectomy, respectively. Five patients with stage IIIC disease were identified with a FN rate of 16.7% and a NPV and PPV of 97.6 and 27.3%, respectively. Overall and bilateral detection rates of ICG SLN mapping were 100 and 97.6%, respectively; no FN were recorded. The identification of patients with stage IIIC disease with ICG SLN mapping showed a NPV and PPV of 100%. Correlation between indication to lymphadenectomy and stage IIIC disease was poor (κ = 0.244) when based on frozen section of the uterus and excellent (κ = 1) when based on SLN mapping.
CONCLUSIONS: ICG SLN mapping reduces the number of unnecessary systematic lymphadenectomies and the risk of underdiagnosing patients with metastatic lymph nodes.

Entities:  

Keywords:  Endometrial cancer; Frozen section; Indocyanine green; Laparoscopy; Sentinel lymph node mapping; Surgical staging

Mesh:

Substances:

Year:  2016        PMID: 27834005     DOI: 10.1007/s00432-016-2303-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.

Authors:  Ilary Ruscito; Maria Luisa Gasparri; Elena Ioana Braicu; Filippo Bellati; Luigi Raio; Jalid Sehouli; Michael D Mueller; Pierluigi Benedetti Panici; Andrea Papadia
Journal:  Ann Surg Oncol       Date:  2016-05-09       Impact factor: 5.344

2.  Sentinel-node biopsy in endometrial cancer: a win-win scenario?

Authors:  Henry C Kitchener
Journal:  Lancet Oncol       Date:  2011-04-12       Impact factor: 41.316

3.  Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.

Authors:  Matteo Morotti; Mario Valenzano Menada; Melita Moioli; Paolo Sala; Ilaria Maffeo; Luca Abete; Ezio Fulcheri; Stefania Menoni; Pierluigi Venturini; Andrea Papadia
Journal:  Gynecol Oncol       Date:  2012-02-21       Impact factor: 5.482

4.  A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer.

Authors:  Sanjeev Kumar; Fabiola Medeiros; Sean C Dowdy; Gary L Keeney; Jamie N Bakkum-Gamez; Karl C Podratz; William A Cliby; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2012-08-29       Impact factor: 5.482

5.  Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.

Authors:  Alessandro Buda; Giampaolo Di Martino; Francesca Vecchione; Beatrice Bussi; Tiziana Dell'Anna; Sharon Palazzi; Maria Grazia Cantù; Martina Delle Marchette; Rodolfo Milani
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

6.  Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.

Authors:  Yukiharu Todo; Hyuck-Jae Choi; Sokbom Kang; Jae-Weon Kim; Joo-Hyun Nam; Hidemichi Watari; Akiko Tamakoshi; Noriaki Sakuragi
Journal:  Gynecol Oncol       Date:  2013-08-14       Impact factor: 5.482

7.  Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.

Authors:  Edward J Tanner; Abdulrahman K Sinno; Rebecca L Stone; Kimberly L Levinson; Kara C Long; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2015-06-19       Impact factor: 5.482

8.  Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer.

Authors:  Abdulrahman K Sinno; Elizabeth Peijnenburg; Amanda N Fader; Sarah M Temkin; Rebecca Stone; Kimberly Levinson; Tricia Murdock; Edward J Tanner
Journal:  Gynecol Oncol       Date:  2016-08-24       Impact factor: 5.482

9.  Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?

Authors:  Andrea Papadia; Sara Imboden; Maria Luisa Gasparri; Franziska Siegenthaler; Anja Fink; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-18       Impact factor: 4.553

10.  Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.

Authors:  Andrea Papadia; Sara Imboden; Franziska Siegenthaler; Maria Luisa Gasparri; Stefan Mohr; Susanne Lanz; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2016-01-20       Impact factor: 5.344

View more
  10 in total

Review 1.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

Review 2.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

3.  Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Authors:  Brooke A Schlappe; Amy L Weaver; Jennifer A Ducie; Ane Gerda Zahl Eriksson; Sean C Dowdy; William A Cliby; Gretchen E Glaser; Robert A Soslow; Kaled M Alektiar; Vicky Makker; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2018-08-31       Impact factor: 5.482

4.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

5.  Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Anda P Radan; Chantal A L Stämpfli; Tilman T Rau; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-24       Impact factor: 4.553

6.  The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Authors:  Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

7.  The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance.

Authors:  Jianbin Guo; Haili Qian; Fei Ma; Ying Zhang; Xiujuan Cui; Hua Duan
Journal:  Ther Adv Med Oncol       Date:  2020-06-13       Impact factor: 8.168

8.  Upregulated keratin 15 links to the occurrence of lymphovascular invasion, stromal cervical invasion as well as unfavorable survival profile in endometrial cancer patients.

Authors:  Hongxiang Yang; Aijing Li; Aili Li; Fei Zhao; Tongyan Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

9.  Effectiveness of Fibrin Sealant Patch in Reducing Drain Volume after Pelvic Lymph Node Dissection in Women with Gynecologic Malignancy.

Authors:  Hwa Cheong Kim; Chahien Choi; Woo Young Kim
Journal:  Biomed Res Int       Date:  2017-11-27       Impact factor: 3.411

10.  Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience.

Authors:  A Santoro; A Piermattei; F Inzani; G Angelico; M Valente; D Arciuolo; S Spadola; M Martini; F Fanfani; A Fagotti; V Gallotta; G Scambia; G F Zannoni
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.